RECRUITING

VENOUS: A Translational Study of Enterococcal Bacteremia

Talk to us

Conditions

Enterococcal Bacteremiaentercoccal bloodstream infectionvancomycin-resistant enterococcivancomycin-susceptible enterococci

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assemble a multicenter prospective cohort of patients with enterococcal bloodstream infections (BSIs) to provide data on outcomes of patients with enterococcal BSIs for sample size calculations for future trials, as well as to characterize enterococcal isolates causing BSIs in order to comprehensively dissect the molecular epidemiology of infecting organisms for future studies.

Official Title

VENOUS: A Translational Study of Enterococcal Bacteremia

Quick Facts

Study Start:2016-08-01
Study Completion:2025-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04410276

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Hospitalized patient
  2. * ≥1 positive blood culture with Enterococcus spp. (VRE or VSE) during hospitalization
  3. * bacterial isolate(s) is/are available for further characterization
  4. * Repeat blood culture(s) within 7 days from the first positive culture
  1. * Cultures obtained from patients not admitted to the hospital
  2. * Isolate(s) not available for further studies.

Contacts and Locations

Study Contact

Cesar A. Arias, MD, MSc, PhD
CONTACT
(713) 500-9000
Cesar.Arias@uth.tmc.edu
Truc T. Tran, PharmD
CONTACT
(713) 500-6748
Truc.T.Tran@uth.tmc.edu

Principal Investigator

Cesar A. Arias, MD, MSc, PhD
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

Jackson Health System, University of Miami Miller School of Medicine
Miami, Florida, 33136
United States
Henry Ford Hospital and Medical Centers
Detroit, Michigan, 48202
United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216
United States
University of North Carolina
Chapel Hill, North Carolina, 27599
United States
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, 15213
United States
MD Anderson Cancer Center
Houston, Texas, 77030
United States
The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Cesar A. Arias, MD, MSc, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-08-01
Study Completion Date2025-08-31

Study Record Updates

Study Start Date2016-08-01
Study Completion Date2025-08-31

Terms related to this study

Keywords Provided by Researchers

  • entercoccal bloodstream infection
  • vancomycin-resistant enterococci
  • vancomycin-susceptible enterococci

Additional Relevant MeSH Terms

  • Enterococcal Bacteremia